Evidence map›Paper›PMID 27964749›Full record

ArticleGenome medicine2016

Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms.

Servi J C Stevens, Anthonie J van Essen, Conny M A van Ravenswaaij, Abdallah F Elias, Jaclyn A Haven, Stefan H Lelieveld, Rolph Pfundt, Willy M Nillesen, Helger G Yntema, Kees van Roozendaal and 3 more

Abstract readCase Reports
In one paragraph

Article in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Methylome-wide Association Study of Patients with Recent-onset Psychosis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. CFrontiers in neurology · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Servi J C StevensDepartment of Clinical Genetics, Maastricht University Medical Center (MUMC+), PO Box 5800, 6202, AZ, Maastricht, The Netherlands. servi.stevens@mumc.nl.
Anthonie J van EssenDepartment of Genetics, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Conny M A van RavenswaaijDepartment of Genetics, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Abdallah F EliasDepartment of Medical Genetics, Shodair Children's Hospital, Helena, MT, USA.
Jaclyn A HavenDepartment of Medical Genetics, Shodair Children's Hospital, Helena, MT, USA.
Stefan H LelieveldDepartment of Genetics, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
Rolph PfundtDepartment of Genetics, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
Willy M NillesenDepartment of Genetics, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
Helger G YntemaDepartment of Genetics, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
Kees van RoozendaalDepartment of Clinical Genetics, Maastricht University Medical Center (MUMC+), PO Box 5800, 6202, AZ, Maastricht, The Netherlands.
Alexander P StegmannDepartment of Clinical Genetics, Maastricht University Medical Center (MUMC+), PO Box 5800, 6202, AZ, Maastricht, The Netherlands.
Christian GilissenDepartment of Genetics, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
Han G BrunnerDepartment of Clinical Genetics, Maastricht University Medical Center (MUMC+), PO Box 5800, 6202, AZ, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKrüppel-type zinc finger genes (ZNF) constitute a large yet relatively poorly characterized gene family. ZNF genes encode proteins that recognize specific DNA motifs in gene promotors. They act as transcriptional co-activators or -repressors via interaction with chromatin remodeling proteins and other transcription factors. Only few ZNF genes are currently linked to human disorders and identification of ZNF gene-associated human diseases may help understand their function. Here we provide genetic, statistical, and clinical evidence to support association of ZNF148 with a new intellectual disability (ID) syndrome disorder.

methodsRoutine diagnostic exome sequencing data were obtained from 2172 patients with ID and/or multiple congenital anomalies.

resultsIn a cohort of 2172 patient-parent trios referred for routine diagnostic whole exome sequencing for ID and/or multiple congenital anomalies (MCA) in the period 2012-2016, four patients were identified who carried de novo heterozygous nonsense or frameshift mutations in the ZNF148 gene. This was the only ZNF gene with recurrent truncating de novo mutations in this cohort. All mutations resulted in premature termination codons in the last exon of ZNF148. The number of the de novo truncating mutations in the ZNF148 gene was significantly enriched (p = 5.42 × 10

conclusionsWe propose ZNF148 as a gene involved in a newly described ID syndrome with a recurrent phenotype and postulate that the ZNF148 is a hitherto unrecognized but crucial transcription factor in the development of the corpus callosum. Our study illustrates the advantage of whole exome sequencing in a large cohort using a parent-offspring trio approach for identifying novel genes involved in rare human diseases.

Indexed as

Base SequenceSequence DeletionAgenesis of Corpus CallosumBody Dysmorphic DisordersChildDevelopmental DisabilitiesDNA-Binding ProteinsFemaleHumansInfant, NewbornMaleTranscription FactorsDNA-Binding ProteinsTranscription FactorsZNF148 protein, humanCorpus callosum developmentDe novo mutationsIntellectual disabilityPremature termination codonWhole exome sequencingZBP-89ZNF148

Identifiers

PMID27964749
PMCPMC5155377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.